Literature DB >> 31844968

Abnormal Lung Clearance Index in Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID) Children with Otherwise Normal FEV1.

Ajay S Kasi1,2, Choo Phei Wee3, Thomas G Keens3, Danieli B Salinas3.   

Abstract

In preschool children with cystic fibrosis (CF), lung clearance index (LCI) is a sensitive test to detect early lung disease. Some children with CF screen positive, inconclusive diagnosis (CFSPID) may in time develop clinical features of CF. LCI has not been studied in CFSPID children. LCI and spirometry were performed in preschool age children with CF, CFSPID, and non-CF healthy controls (HCs) during two visits. Fifty-four preschool age children (HC n = 18, CFSPID n = 17, and CF n = 19) were tested. Mean LCI from the CFSPID group was not statistically different from HC (p = 0.49), but significantly different when compared to CF (p = 0.04). LCI was abnormal in 2 CFSPID children who carried potentially deleterious CFTR variants. Mean forced expiratory volume in 1 s (FEV1) was not statistically different between CFSPID and CF (p = 0.26). LCI can potentially detect early lung disease in CFSPID individuals as part of assessing their risk for reclassification to CF diagnosis.

Entities:  

Keywords:  CFSPID; CFTR-related metabolic syndrome; CRMS; Cystic fibrosis; Early lung disease; Lung clearance index

Mesh:

Year:  2019        PMID: 31844968     DOI: 10.1007/s00408-019-00307-3

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  23 in total

1.  Spirometric pulmonary function in healthy preschool children.

Authors:  H Eigen; H Bieler; D Grant; K Christoph; D Terrill; D K Heilman; W T Ambrosius; R S Tepper
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

2.  Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making.

Authors:  Philip H Quanjer; Daniel J Weiner; Jeffrey J Pretto; Danny J Brazzale; Piotr W Boros
Journal:  Eur Respir J       Date:  2013-09-26       Impact factor: 16.671

3.  Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement.

Authors:  Bruce H Culver; Brian L Graham; Allan L Coates; Jack Wanger; Cristine E Berry; Patricia K Clarke; Teal S Hallstrand; John L Hankinson; David A Kaminsky; Neil R MacIntyre; Meredith C McCormack; Margaret Rosenfeld; Sanja Stanojevic; Daniel J Weiner
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

4.  Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline.

Authors:  Padmaja Subbarao; Sanja Stanojevic; Meghan Brown; Renee Jensen; Margaret Rosenfeld; Stephanie Davis; Lyndia Brumback; Per Gustafsson; Felix Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2013-08-15       Impact factor: 21.405

5.  Spirometry in early childhood in cystic fibrosis patients.

Authors:  Daphna Vilozni; Lea Bentur; Ori Efrati; Tal Minuskin; Asher Barak; Amir Szeinberg; Hannah Blau; Elie Picard; Eitan Kerem; Yaacov Yahav; Arie Augarten
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

6.  Sensitivity of Lung Clearance Index and chest computed tomography in early CF lung disease.

Authors:  Helmut Ellemunter; Susanne I Fuchs; Karin M Unsinn; Martin C Freund; Maria Waltner-Romen; Gratiana Steinkamp; Monika Gappa
Journal:  Respir Med       Date:  2010-07-15       Impact factor: 3.415

7.  Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign.

Authors:  Joshua D Groman; Timothy W Hefferon; Teresa Casals; Lluís Bassas; Xavier Estivill; Marie Des Georges; Caroline Guittard; Monika Koudova; M Daniele Fallin; Krisztina Nemeth; Gyorgy Fekete; Ludovit Kadasi; Ken Friedman; Martin Schwarz; Cristina Bombieri; Pier Franco Pignatti; Emmanuel Kanavakis; Maria Tzetis; Marianne Schwartz; Giuseppe Novelli; Maria Rosaria D'Apice; Agnieszka Sobczynska-Tomaszewska; Jerzy Bal; Manfred Stuhrmann; Milan Macek; Mireille Claustres; Garry R Cutting
Journal:  Am J Hum Genet       Date:  2003-12-18       Impact factor: 11.025

8.  Phenotypes of California CF Newborn Screen-Positive Children with CFTR 5T Allele by TG Repeat Length.

Authors:  Danieli Barino Salinas; Colleen Azen; Suzanne Young; Thomas G Keens; Martin Kharrazi; Richard B Parad
Journal:  Genet Test Mol Biomarkers       Date:  2016-07-22

9.  Spirometry in 3- to 6-year-old children with cystic fibrosis.

Authors:  Paulo J C Marostica; Andrea D Weist; Howard Eigen; Connie Angelicchio; Kathy Christoph; Julie Savage; Debra Grant; Robert S Tepper
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

10.  Nationwide genetic analysis for molecularly unresolved cystic fibrosis patients in a multiethnic society: implications for preconception carrier screening.

Authors:  Doron M Behar; Ori Inbar; Michal Shteinberg; Michal Gur; Huda Mussaffi; David Shoseyov; Moshe Ashkenazi; Soliman Alkrinawi; Concetta Bormans; Fahed Hakim; Meir Mei-Zahav; Malena Cohen-Cymberknoh; Adi Dagan; Dario Prais; Ifat Sarouk; Patrick Stafler; Bat El Bar Aluma; Gidon Akler; Elie Picard; Micha Aviram; Ori Efrati; Galit Livnat; Joseph Rivlin; Lea Bentur; Hannah Blau; Eitan Kerem; Amihood Singer
Journal:  Mol Genet Genomic Med       Date:  2017-02-19       Impact factor: 2.183

View more
  3 in total

1.  Multiple Breath Washout for Early Assessment of Pulmonary Complications in Patients With Primary Antibody Deficiencies: An Observational Study in Pediatric Age.

Authors:  Teresa Secchi; Lucia Augusta Baselli; Maria Chiara Russo; Irene Maria Borzani; Federica Carta; Maria Amalia Lopopolo; Michaela Foà; Adriano La Vecchia; Carlo Agostoni; Massimo Agosti; Rosa Maria Dellepiane
Journal:  Front Pediatr       Date:  2022-05-17       Impact factor: 3.569

2.  LUNG Year in Review: 2020.

Authors:  Peter V Dicpinigaitis
Journal:  Lung       Date:  2021-01-26       Impact factor: 2.584

3.  CRMS/CFSPID Subjects Carrying D1152H CFTR Variant: Can the Second Variant Be a Predictor of Disease Development?

Authors:  Vito Terlizzi; Rita Padoan; Laura Claut; Carla Colombo; Benedetta Fabrizzi; Marco Lucarelli; Sabina Maria Bruno; Alice Castaldo; Paolo Bonomi; Giovanni Taccetti; Antonella Tosco
Journal:  Diagnostics (Basel)       Date:  2020-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.